Menu
Recruiting NCT07176910

Doppler Ultrasound-Guided Angiopuncture for Dysmenorrhea Pain: A Clinical Trial

No phase Interventional Angiopuncture Dysmenorrhea Dopplar Ultrasound

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: conduct angiopuncture on perforator points.
Who it may be relevant to
Registry conditions: Angiopuncture, Dysmenorrhea, Dopplar Ultrasound. Basic parameters: 18 years — 25 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

the study is to evaluated dopplar guided angiopuncture efficacy and safety in patients with dysmenorrhea

Detailed description

to conduct angiopuncture, with dopplar located perforator points and also evaluate the spectrum before and after angiopuncture therapy.

Interventions

  • Other conduct angiopuncture on perforator points
    conducted angiopuncutre on patients of intervention group, and compare those patients pain scores before and after angiopuncture therapy.

Primary outcome measures

  • visual analog scale [Time frame: pre-treatment, immediate post-treatment, check up 1, check up 2, check up 3 (3 check ups lasts for 3 months post therapy, with each for 1 month)]

Eligibility criteria

Inclusion criteria

Primary dysmenorrhea diagnosis (≥6 months of menstrual pain scoring ≥2 on numerical rating scale) Regular menstrual cycles (28-32 days), menstrual period lasts 4 to 7 days No pelvic pathology on transvaginal ultrasound.

Exclusion criteria

coagulopathy (INR >1.5) recent analgesic use (48-hour washout) secondary dysmenorrhea confirmed by laparoscopy.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

China · 1 center
  • The Third Affiliated Hospital of Changchun University of Chinese Medicine — Changchun

Identifiers

NCT: NCT07176910 · 111 · 9239056

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗